Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, Myotonia, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease	Recruiting	Not stated	2026-08-11		NCT06747884

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Institute of Neurological Disorders and Stroke (NINDS)	370
Roseman University of Health Sciences	1
SUNY Research Foundation	4
University of California, San Diego	337
University of Glasgow	73
University of Kansas Medical Center	169
University of Minnesota	344
Virginia Commonwealth University	122

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Arkansas Children's Hospital	Little Rock	United States	82
Hospital das Clínicas, University of São Paulo School of Medicine (HCFMUSP)	Cerqueira César	Brazil	1
University of Kansas Medical Center	Kansas City	United States	240
Virginia Commonwealth University	Richmond	United States	156